Byung Soo Kim, MD

Articles

Epirubicin, Cisplatin, Oral UFT, and Calcium Folinate in Advanced Gastric Carcinoma

Yeul Hong Kim, MD;Byung Soo Kim, MD;Jae Hong Seo, MD;Cheol Won Choi, MD;Jun Suk Kim, MD;Jae Sun Kim, MD;Hoon Jai Chun, MD;Jin Hai Hyun, MD

July 1st 1999

UFT (uracil and tegafur in a 4:1 molar ratio) plus calcium folinate treatment has favorable activity and tolerable toxicity in patients with advanced gastric carcinoma. High response rates have been reported in patients with

Oral UFT and Leucovorin in Patients With Advanced Gastric Carcinoma

Yeul Hong Kim, MD;Sang Won Shin, MD;Byung Soo Kim, MD;Young Tae Park, MD;Jongguk Kim, MD;Jun Suk Kim, MD

September 2nd 1997

Thirty-nine patients with locally advanced or metastatic gastric carcinoma received oral UFT (tegafur and uracil) plus leucovorin. Treatment consisted of UFT 360 mg/m2/day plus leucovorin 25 mg/m2/day, given orally in divided